On Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q3 2022 earnings per share (EPS) of -$1.28, up 74.35% year over year. Total Biorestorative Therapies earnings for the quarter were -$4.66 million. In the same quarter last year, Biorestorative Therapies's earnings per share (EPS) was -$4.99.
As of Q1 2023, Biorestorative Therapies's earnings has grown year over year. Biorestorative Therapies's earnings in the past year totalled -$34.55 million.
What was BRTX's revenue last quarter?
On Invalid Date, Biorestorative Therapies (NASDAQ: BRTX) reported Q3 2022 revenue of $29.00 thousand up 262.5% year over year. In the same quarter last year, Biorestorative Therapies's revenue was $8.00 thousand.
What was BRTX's revenue growth in the past year?
As of Q1 2023, Biorestorative Therapies's revenue has grown 108.79% year over year. This is 45.59 percentage points higher than the US Biotechnology industry revenue growth rate of 63.2%. Biorestorative Therapies's revenue in the past year totalled $121.10 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.